By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
100 years of scientific excellence in producing Bacteriophages as sustainable antibacterial solutions.
We are committed to developing innovative solutions that combat AMR - the growing threat of bacterial resistance and improve human and animal health. With decades of expertise and a rich scientific legacy, we harness the power of bacteriophages – nature's own creations that target and destroy specific bacteria.
Our aim is to use the unique knowledge and experience of the Eliava Institute to produce highly effective and safe bacteriophage preparations for use in human health, veterinary and environmental care. At Eliava BioPreparation we use natural bacteriophages, offering a sustainable and targeted approach to combat bacterial infections in animals, humans and environment . We embrace the One Health approach, recognizing the interconnectedness of human health, animal health, and the environment. By promoting the principles of One Health, we strive to achieve holistic solutions that improve the well-being of individuals, animals, and the planet.
EBP employs more than 30 scientists and phage production specialists full time, has 6 human health and several customized veterinary products on the market.
Co-invest alongside Ventures Thrive to accelerate the next generation of deeptech startups.
%20Turkey.webp)
Be a mentor, address key industry challenges, or co-invest alongside Ventures Thrive to accelerate the next generation of deeptech startups.
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Innovation Council and SMEs Executive Agency (EISMEA). Neither the European Union nor the granting authority can be held responsible for them.
Ventures Thrive, project No 101073762 has received funding from the European Union’s Horizon Europe framework programme, under the European Innovation Council’s StartUpEU initiative.
